COVID-19 situation across Europe and central Asia is very serious. According to WHO, Europe could face over 2 million COVID-19 deaths by March 2022. Wearing...
Molnupiravir, the world’s first oral drug (approved by MHRA, UK) against COVID-19 along with upcoming drugs such as Paxlovid and sustained vaccination drive has raised hopes...
LZTFL1 expression causes high levels of TMPRSS2, by inhibiting EMT (epithelial mesenchymal transition), a developmental response involved in wound healing and recovery from disease. In a...
TMPRSS2 is an important drug target to develop anti-viral drugs against COVID-19. MM3122 is a lead candidate that has shown promising result in vitro and in...
Coronaviruses are RNA viruses belonging to coronaviridae family. These viruses display remarkably high rates of errors during replication due to lack of proofreading nuclease activity of their polymerases....
Advanced age and comorbidities are known to be high risk factors for COVID-19. Does genetic make-up predispose some people making them more susceptible to...
In the practice of medicine, one generally prefers time tested proven path while treating and trying to prevent diseases. An innovation is usually expected...